Fluorescence Imaging of Adalimumab-680LT in Inflammatory Bowel Disease

First, adalimumab-680LT was administered intravenously. 2-3 days later, a Fluorescence Molecular Imaging procedure was performed to enable the visualisation and detection of fluorescence signals.

Fluorescence Molecular Imaging was performed to enable the visualisation and detection of fluorescence signals.